Today: August 29, 2015, 2:39 pm

Top 5 Emerging Markets OTC pharmaceuticals market: $26.3 billion industry estimated during 2012
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide - a new market research report on 2014-04-21 12:18:02
These countries contributed $26,323.4 million to the global OTC pharmaceuticals industry in 2012, with a compound annual growth rate (CAGR) of 7.8% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $38,522.5 million in 2017, with a CAGR of 7.9% over the 2012-17 period.

Within the OTC pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $15,615.7 million in 2012. This was followed by Brazil and Mexico with a value of $5,771.9 and $2,340.5 million, respectively.

China is expected to lead the OTC pharmaceuticals industry in the top five emerging nations, with a value of $21,948.0 million in 2017, followed by Brazil and India with expected values of $9,908.9 and $2,913.5 million, respectively.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.